Researchers

SERIZAWA Kentaro

SERIZAWA Kentaro: Lecturer

Faculty	Department of Medicine
Researchmap	https://researchmap.jp/saken

Education and Career

Education

- Today , Kindai University, Faculty of Medicine,

Academic & Professional Experience

- Today , Kindai University Faculty of Medicine 講師

Research Activities

Research Areas

Life sciences, Hematology and oncology

Published Papers

Long-term effectiveness and safety of high dose chemotherapy followed by autologous stem cell transplantation in daily practice in patients with diffuse large B-cell lymphoma.
Takahiro Haeno; Shinya Rai; Yoshiaki Miyake; Maiko Inoue; Ko Fujimoto; Aki Fujii; Yoshio Iwata; Shuji Minamoto; Takahide Taniguchi; Hiroaki Kakutani; Hiroaki Inoue; Takahiro Kumode; Kentaro Serizawa; Yasuhiro Taniguchi; Chikara Hirase; Yasuyoshi Morita; Hirokazu Tanaka; Yoichi Tatsumi; Takashi Ashida; Itaru Matsumura
Journal of clinical and experimental hematopathology : JCEH 63 (2) , 99-107, 28, Jun. 2023
Chlorpromazine cooperatively induces apoptosis with tyrosine kinase inhibitors in EGFR-mutated lung cancer cell lines and restores the sensitivity to gefitinib in T790M-harboring resistant cells.
Ryosuke Fujiwara; Yasuhiro Taniguchi; Shinya Rai; Yoshio Iwata; Aki Fujii; Ko Fujimoto; Takahiro Kumode; Kentaro Serizawa; Yasuyoshi Morita; J Luis Espinoza; Hirokazu Tanaka; Hitoshi Hanamoto; Itaru Matsumura
Biochemical and biophysical research communications 626 , 156-166, 10, Aug. 2022
C-type lectin-like receptor 2 specifies a functionally distinct subpopulation within phenotypically defined hematopoietic stem cell population that contribute to emergent megakaryopoiesis.
Takahiro Kumode; Hirokazu Tanaka; Jorge Luis Esipinoza; Shinya Rai; Yasuhiro Taniguchi; Ryosuke Fujiwara; Keigo Sano; Kentaro Serizawa; Yoshio Iwata; Yasuyoshi Morita; Itaru Matsumura
International journal of hematology 115 (3) , 310-321, Mar. 2022

十二指腸原発濾胞性リンパ腫における抗腫瘍免疫の寄与 , 井上宏昭; 頼晋也; 口分田貴裕; 芹澤憲太郎; 谷口康博; 中山聖子; 森田泰慶; Luis Espinoza J; 田中宏和; 辰巳陽一; 芦田隆司; 松村到 , 日本リンパ網内系学会会誌 , May. 2019
末梢血幹細胞採取前のCD34細胞数測定の有用性 , 山田枝里佳; 斉藤花往里; 藤本昂; 角谷宏明; 岩田吉生; 谷口貴英; 源周治; 大山泰世; 口分田貴裕; 井上宏昭; 芹澤憲太郎; 谷口康博; 頼晋也; 平瀬主税; 森田泰慶; 田中宏和; 岡野意浩; 坂田尚己; 芦田隆司; 松村到 , 日本アフェレシス学会雑誌 , Oct. 2018
KMFに登録されたボルテゾミブとIMiDs両剤に抵抗性の再発骨髄腫の予後解析(Clinical outcomes of relapsed myeloma, dual refractory to bortezomib and IMiDs in KMF registry) , 藤原亮介; 田中宏和; 芹澤憲太郎; 金子仁臣; 志村勇司; 太田健介; 淵田真一; 中谷綾; 諫田淳也; 八木秀男; 和田勝也; 小杉智; 魚嶋伸彦; 柴山浩彦; 小原尚恵; 中谷英仁; 内山人二; 足立陽子; 飯田正人; 濱田常義; 松田光弘; 高折晃史; 野村昌作; 島崎千尋; 日野雅之; 黒田純也; 谷脇雅史; 今田和典; 金倉譲; 松村到 , 臨床血液 , Sep. 2018

【多発性骨髄腫update-診断・治療の最新動向-】病態骨髄腫進展の細胞遺伝学的病態 , 田中宏和; 芹澤憲太郎; 松村到 , 日本臨床 , 81 , 6 , 806 , 812 , Jun. 2023
再発・抵抗性多発性骨髄腫におけるcell-free DNAの意義 , 田中宏和; 芹澤憲太郎; 松村到 , 血液内科 , 86 , 2 , 266 , 271 , Feb. 2023
Recent trends in basic research on myeloma initiating cells. , 田中宏和; 芹澤憲太郎; 松村到 , 月刊血液内科 , 84 , 4 , 2022